ClinicalTrials.gg
WithdrawnNCT02388178Updated Sep 27, 2022

To Determine the Ability of a New Product Formulation to Remineralize an Early Caries Lesion by an In-situ Study

A Phase 2 interventional study of Control toothpaste containing no anti-cavity ingredients and Experimental toothpaste containing fluoride and amino acid (arginine) in Dental Caries, sponsored by Colgate Palmolive. Withdrawn. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-27.

Sponsored by Colgate Palmolive · Phase 2, Interventional, and Treatment

Why this study was withdrawn
The study was stopped due to business reasons.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This is a double blind, cross-over, controlled clinical trial utilizing thirty (30) adults to evaluate remineralization of early caries lesions.

02

Conditions studied

  • Dental Caries

Browse trials for

03

In context

Dental Caries

1,174 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

Browse Dental Caries studies →

Lead sponsor

Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male and/or female subjects 18 to 50 years inclusive
  2. Minimum of 20 natural uncrowned teeth (excluding third molars) must be present
  3. Willing to wear retainer 24 hours per day
  4. No active, unrestored cavities
  5. Have normal salivary flow rate (stimulated and unstimulated flow of ≥0.7 ml/min and ≥ 0.2 ml/min respectively) ascertained from a preliminary sialometry
  6. Available throughout entire study
  7. Willing to use only assigned products for oral hygiene throughout the duration of the study
  8. Must give written
  9. Must be in good general health
  10. No known history of allergy to personal care/consumer products or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study

Exclusion criteria

Exclusion Criteria:

  1. Advanced periodontal disease
  2. Medical condition which requires premedication prior to dental visits/procedures
  3. Not enough teeth to secure the oral retainer
  4. Diseases of the soft or hard oral tissues
  5. Wear an Orthodontic appliances
  6. Impaired salivary function
  7. Current use drugs that can affect salivary flow
  8. Use antibiotics one (1) month prior to or during this study
  9. Pregnant or breastfeeding
  10. Participate in another clinical study one (1) week prior to the start of the or during this 9-week study period
  11. Use tobacco products
  12. Allergic to common toothpaste ingredients
  13. Allergic to amino acids
  14. Immune compromised individuals (, AIDS, immuno-suppressive drug therapy)
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Washout period

A planned gap after a treatment, so that its effects can lessen before the study treatment or a study assessment. Ask the study team and the doctor who prescribed it before changing any medicine.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Placebo comparator
    Fluoride free, silica based toothpaste

    Control toothpaste containing no anti-cavity ingredients

    Drug: Control toothpaste containing no anti-cavity ingredients · Drug: Experimental toothpaste containing fluoride and amino acid (arginine) · Drug: Fluoride toothpaste containing fluoride as the anti-cavity ingredient

  • Experimental
    fluoride + amino acid in a silica toothpaste

    Experimental toothpaste containing fluoride and amino acid (arginine)

    Drug: Control toothpaste containing no anti-cavity ingredients · Drug: Experimental toothpaste containing fluoride and amino acid (arginine) · Drug: Fluoride toothpaste containing fluoride as the anti-cavity ingredient

  • Active comparator
    1450 ppm fluoride in a silica base toothpaste

    Fluoride toothpaste containing fluoride as the anti-cavity ingredient

    Drug: Control toothpaste containing no anti-cavity ingredients · Drug: Experimental toothpaste containing fluoride and amino acid (arginine) · Drug: Fluoride toothpaste containing fluoride as the anti-cavity ingredient

Interventions

  • DrugControl toothpaste containing no anti-cavity ingredients

    Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait for 1 minute before rinsing with water.

    Also known as: Fluoride free toothpaste control

  • DrugExperimental toothpaste containing fluoride and amino acid (arginine)

    Drug page: Arginine

    Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait for 1 minute before rinsing with water.

    Also known as: Experimental toothpaste

  • DrugFluoride toothpaste containing fluoride as the anti-cavity ingredient

    Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait for 1 minute before rinsing with water.

    Also known as: Fluoride only toothpaste control

06

What researchers measure

Primary outcomes

  1. Mineral Change (delta Z)

    Tooth samples of human enamel are placed in a retainer and worn by each study subject. Enamel block samples will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions , vol% µm) before being placed in the retainer. These baseline values will be compared with the post use delta mineral change (∆ Z).

    Time frame: Baseline

  2. Mineral Change (delta Z)

    Tooth samples of human enamel are placed in a retainer and worn by each study subject. After 2 weeks of wearing the study retainer, samples from the retainer will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions , vol% µm). These post use values will be compared to the Baseline values to give a delta mineral change (∆ Z).

    Time frame: 2 weeks (from Baseline)

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2015, a primary completion of Jul 2015 and a completion of Jul 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2015
First posted
Mar 13, 2015
Start
Apr 2015
Primary completionEst.
Jul 2015
CompletionEst.
Jul 2015
Last update
Sep 27, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02388178
Lead sponsor
Colgate Palmolive
Responsible party
Sponsor
First posted
Mar 13, 2015
Start date
Apr 2015
Primary completion
Jul 2015 (estimated)
Completion
Jul 2015 (estimated)
Last update
Sep 27, 2022

Study contacts

Bennet Amaechi, PhD, DDS
principal investigator · University of Texas

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Arginine

Start the discussion